Therapy For Staphylococcus Aureus

Abstract

The present invention is directed to methods for treating infections caused by Staphylococcus aureus with reduced glycopeptide sensitivity. The invention is preferably practiced with strains of Staphylococcus aureus which are methicillin resistant, such as the Mu5O strain.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 30, 1999
  • Application: Jul 15, 1998
    US US 11602598 A
  • Priority: Jul 15, 1998
    US US 11602598 A
  • Priority: Aug 22, 1997
    US US 5671297 P

Download Citation


Sign in to the Lens

Feedback